Cargando…
Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer
Rhenium (I)-diselenother (Re-diselenoether) is a water soluble metal-based compound, combining one atom of rhenium and two atoms of selenium. This compound has been reported to exhibit marked activities against several solid tumor cell lines. We now disclose an improved synthesis of this complex. Th...
Autores principales: | Collery, Philippe, Mohsen, Ahmed, Kermagoret, Anthony, Corre, Samantha, Bastian, Gérard, Tomas, Alain, Wei, Ming, Santoni, François, Guerra, Nadia, Desmaële, Didier, d’Angelo, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491361/ https://www.ncbi.nlm.nih.gov/pubmed/26108551 http://dx.doi.org/10.1007/s10637-015-0265-z |
Ejemplares similares
-
Antitumor activity of recombinant RGD-IFN-α2a-core fusion protein in vitro
por: Wen, Zhengwei, et al.
Publicado: (2017) -
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
por: Zhou, You, et al.
Publicado: (2019) -
RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models
por: Garner, Fiona, et al.
Publicado: (2015) -
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
por: Bergman, Andries M., et al.
Publicado: (2010) -
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)